Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Esser

Showing results (81-90 of 167) with videos related to

Pageof 17
Sort By:
Infection|March 24, 2024
Hypercalcemia as a rare manifestation of immune reconstitution inflammatory syndrome (IRIS) in a person living with Human Immunodeficiency Virus (HIV) with disseminated nontuberculous mycobacteriosisMaximilian Webendoerfer, Margarethe Konik, Markus Zettler, et al.
Current HIV Research|April 18, 2013
Long-term gender-based outcomes for atazanavir/ritonavir (ATV/r)- containing regimens in treatment-experienced patients with HIVVeronica Svedhem-Johansson, Pascal Pugliese, Norbert H Brockmeyer, et al.
BMC Public Health|December 12, 2025
HPV knowledge and acceptance of HPV vaccination among men who have sex with men (MSM) in Germany: a multicenter, observational, cross-sectional studyCornelia Wähner, Lisa M Lang, Maher Almahfoud, et al.
Antiviral Therapy|May 4, 2005
The steady-state pharmacokinetics of nelfinavir in combination with tenofovir in HIV-infected patientsGuido Kruse, Stefan Esser, Hartmut Stocker, et al.
AIDS (London, England)|December 14, 2019
Week 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patientsChloe Orkin, Joseph J Eron, Jürgen Rockstroh, et al.
Inflammation & Allergy Drug Targets|February 18, 2012
Detection of abacavir hypersensitivity by ELISpot methodStefan Esser, Robert Jablonka, Falko M Heinemann, et al.
International Journal of Cardiology|July 19, 2011
Oral health and the heart - does HIV infection open a pathophysiological gateway?Bianca Gelbrich, Till Neumann, Stefan Esser, et al.
Medical Microbiology and Immunology|April 5, 2011
HIV prevalence and route of transmission in Turkish immigrants living in North-Rhine Westphalia, GermanyEugen Schülter, Mark Oette, Melanie Balduin, et al.
AIDS (London, England)|March 21, 2003
Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wastingUlrich R Hengge, Kristin Stocks, Heidi Wiehler, et al.
Journal of Virological Methods|October 15, 2016
Development of a phenotypic susceptibility assay for HIV-1 integrase inhibitorsEva Heger, Alexandra Andrée Theis, Klaus Remmel, et al.
Pageof 17

Showing results (81-90 of 167) with videos related to

Sort By:
Pageof 17
Infection|March 24, 2024
Hypercalcemia as a rare manifestation of immune reconstitution inflammatory syndrome (IRIS) in a person living with Human Immunodeficiency Virus (HIV) with disseminated nontuberculous mycobacteriosisMaximilian Webendoerfer, Margarethe Konik, Markus Zettler, et al.
Current HIV Research|April 18, 2013
Long-term gender-based outcomes for atazanavir/ritonavir (ATV/r)- containing regimens in treatment-experienced patients with HIVVeronica Svedhem-Johansson, Pascal Pugliese, Norbert H Brockmeyer, et al.
BMC Public Health|December 12, 2025
HPV knowledge and acceptance of HPV vaccination among men who have sex with men (MSM) in Germany: a multicenter, observational, cross-sectional studyCornelia Wähner, Lisa M Lang, Maher Almahfoud, et al.
Antiviral Therapy|May 4, 2005
The steady-state pharmacokinetics of nelfinavir in combination with tenofovir in HIV-infected patientsGuido Kruse, Stefan Esser, Hartmut Stocker, et al.
AIDS (London, England)|December 14, 2019
Week 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patientsChloe Orkin, Joseph J Eron, Jürgen Rockstroh, et al.
Inflammation & Allergy Drug Targets|February 18, 2012
Detection of abacavir hypersensitivity by ELISpot methodStefan Esser, Robert Jablonka, Falko M Heinemann, et al.
International Journal of Cardiology|July 19, 2011
Oral health and the heart - does HIV infection open a pathophysiological gateway?Bianca Gelbrich, Till Neumann, Stefan Esser, et al.
Medical Microbiology and Immunology|April 5, 2011
HIV prevalence and route of transmission in Turkish immigrants living in North-Rhine Westphalia, GermanyEugen Schülter, Mark Oette, Melanie Balduin, et al.
AIDS (London, England)|March 21, 2003
Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wastingUlrich R Hengge, Kristin Stocks, Heidi Wiehler, et al.
Journal of Virological Methods|October 15, 2016
Development of a phenotypic susceptibility assay for HIV-1 integrase inhibitorsEva Heger, Alexandra Andrée Theis, Klaus Remmel, et al.
Pageof 17